Inclusion Criteria:  Male or female, aged 18 years or above Participants who have an estimated glomerular filtration rate between 15 and 45 ml/min/1.73m2 Serum potassium concentration between 4.9 and 5.5 milliequivalent (mEq)/L Hemoglobin A1c < 11% Are registered in the multidisciplinary nephrology clinic in Winnipeg Able to communicate in English and provide written informed consent  Exclusion Criteria:  Serum potassium concentration > 5.4 mEq/L, anuria, dialysis, or acute kidney injury failure in the 6 months prior to screening Chronic obstructive pulmonary disease that requires the participant to be on oxygen New York Heart Association Class 3-4 Heart failure symptoms or heart, liver or renal transplant A myocardial infarction or stroke within the last 6 months Unable to consume study treatments or control, such as swallowing or gastro-intestinal issues Currently on potassium binding therapy In the opinion of the investigator any medical condition, uncontrolled systemic disease or concurrent illness that would decrease the study compliance or jeopardize the safety of the participant Female participant who is pregnant or lactating